Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

Clinical Trials

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

OUTREACH

A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors

Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

Phase I of XKH002 Injection in Patients

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer

AMT-562 in Patients With Selected Advanced Solid Tumors

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone

A Study of HY-0102 in Patients With Advanced Solid Tumors

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

U87 CART in Treatment of Advanced Solid Tumor

A Study of sEphB4-HSA in Kaposi Sarcoma

A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

KICKSTART

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

LUCIDA

LUCIDA_2

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors

Phase II Clinical Study of LTC004 in Patients With mCRC

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy

A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors

A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma

BM201-1001

Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours